Ingevity Corporation (NYSE:NGVT) Given Consensus Rating of “Hold” by Brokerages

Shares of Ingevity Corporation (NYSE:NGVT) have been given an average recommendation of “Hold” by the five analysts that are covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12-month price target among analysts that have covered the stock in the last year is $80.00.

NGVT has been the subject of a number of recent research reports. Weiss Ratings upgraded Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Friday, July 31st. Wall Street Zen downgraded shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 1st.

Insider Transactions at Ingevity

In related news, SVP Ryan Fisher sold 2,709 shares of the firm’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $73.72, for a total value of $199,707.48. Following the sale, the senior vice president owned 15,722 shares in the company, valued at approximately $1,159,025.84. This trade represents a 14.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO David Li sold 5,000 shares of the firm’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $75.83, for a total value of $379,150.00. Following the completion of the transaction, the chief executive officer owned 120,636 shares in the company, valued at approximately $9,147,827.88. This trade represents a 3.98% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 17,801 shares of company stock worth $1,347,481. Insiders own 0.88% of the company’s stock.

Institutional Investors Weigh In On Ingevity

Several large investors have recently added to or reduced their stakes in NGVT. BlackRock Inc. purchased a new stake in shares of Ingevity in the second quarter valued at approximately $400,545,000. California State Teachers Retirement System increased its position in Ingevity by 7,309.2% during the 2nd quarter. California State Teachers Retirement System now owns 3,003,451 shares of the company’s stock valued at $224,268,000 after purchasing an additional 2,962,914 shares during the period. Millennium Management LLC raised its holdings in shares of Ingevity by 1.3% in the 3rd quarter. Millennium Management LLC now owns 1,189,524 shares of the company’s stock valued at $65,650,000 after purchasing an additional 15,562 shares in the last quarter. Royce & Associates LP raised its stake in Ingevity by 7.7% in the fourth quarter. Royce & Associates LP now owns 1,111,158 shares of the company’s stock worth $65,758,000 after buying an additional 79,059 shares in the last quarter. Finally, Brown Advisory Inc. lifted its holdings in Ingevity by 15.4% during the fourth quarter. Brown Advisory Inc. now owns 1,040,944 shares of the company’s stock worth $61,603,000 after buying an additional 138,859 shares during the period. 91.59% of the stock is owned by institutional investors.

Ingevity Price Performance

Shares of NYSE:NGVT opened at $69.64 on Monday. Ingevity has a twelve month low of $45.85 and a twelve month high of $79.29. The stock’s 50 day moving average is $72.63 and its 200-day moving average is $71.44. The company has a quick ratio of 1.15, a current ratio of 1.61 and a debt-to-equity ratio of 22.52. The firm has a market capitalization of $2.39 billion, a price-to-earnings ratio of 47.38 and a beta of 1.17.

Ingevity (NYSE:NGVT) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $1.74 EPS for the quarter, topping the consensus estimate of $1.33 by $0.41. Ingevity had a return on equity of 284.70% and a net margin of 4.65%.The firm had revenue of $314.10 million during the quarter, compared to the consensus estimate of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Sell-side analysts forecast that Ingevity will post 5.4 EPS for the current fiscal year.

Ingevity Company Profile

Ingevity Corporation (NYSE: NGVT) is a specialty chemicals and materials company that develops products designed to improve performance, sustainability and resource efficiency across a range of industrial and consumer applications. Its businesses serve automotive, infrastructure, industrial, agricultural and other end markets.

The company’s portfolio includes activated carbon products used in vehicle evaporative-emissions control systems, industrial air and water purification, and other filtration applications.